A Johns Hopkins Medicine study involving a dozen people with the inflammatory skin disease hidradenitis suppurativa (HS), which mostly affects skin folds, is believed to be the first to provide ...

SAN ANTONIO -- The antibody-drug conjugate (ADC) sacituzumab govitecan (Trodelvy) failed to outperform chemotherapy as first ...

In an international study led by UCLA, researchers have shown that giredestrant, a next-generation oral selective estrogen ...

Please provide your email address to receive an email when new articles are posted on . Those who were exposed to low levels of nuclear radiation were more likely to develop diabetes, according to ...

NEW YORK (Reuters Health) - Handling receipts may increase the body's level of a chemical that has been linked to reproductive and neurological problems, suggests a new small study. The researchers ...

(Beyond Pesticides, December 17, 2024) A systematic review of studies on pesticides as endocrine-disrupting chemicals (EDCs) on body weight, published in Biomedicines, evaluates 36 clinical and ...

The PERSEPHONE trial: Duration of trastuzumab with chemotherapy in women with HER2-positive early breast cancer. Background: Approximately 50% of human epidermal growth factor receptor 2 positive ...

About one in six women of reproductive age face difficulties in conceiving or carrying a pregnancy to term. Although there has been a global increase in the use of assisted reproductive technologies ...

JACKSON TWP. – A local medical provider said it is participating in a nationwide research project examining the potential impact of three medications created for other ailments to reduce COVID-19 ...